ask="7.75"
ask_size="100"
average_daily_volume="968955"
bid="5.51"
bid_size="1000"
book_value="0.05"
change="-0.12"
change_from_200_day_moving_average="1.21"
change_from_50_day_moving_average="-0.16"
change_from_52_week_high="-1.38"
change_From_52_week_low="4.55"
change_in_percent="-1.90%"
close="6.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="42554000"
high="6.41"
high_52_weeks="7.56"
last_trade_date="2/1/2017"
last_trade_price="6.18"
last_trade_size="26790"
last_trade_time="4:00pm"
low="6.16"
low_52_weeks="1.63"
market_capitalization="455.82M"
moving_average_200_day="4.97"
moving_average_50_day="6.34"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="6.32"
pe_ratio="N/A"
peg_ratio="-0.35"
percent_change_from_200_day_moving_average="+24.34%"
percent_change_from_50_day_moving_average="-2.57%"
percent_change_from_52_week_high="-18.25%"
percent_change_from_52_week_low="+279.14%"
previous_close="6.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="116.67"
price_per_sales="21.15"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="6.39"
stock_exchange="NMS"
symbol="BCRX"
volume="612653"
weeks_range_52="1.63 - 7.56"
